Clinical Report: Infection with Mycobacterium abscessus in a Young Adult Diagnosed with Cystic Fibrosis
Overview
This case study presents a 21-year-old male with cystic fibrosis (CF) who developed a Mycobacterium abscessus infection. The patient achieved clinical stability through a tailored antimycobacterial regimen despite challenges in accessing CFTR modulator therapy.
Background
Cystic fibrosis is a genetic disorder that often leads to severe respiratory complications and increased susceptibility to infections, including those caused by multidrug-resistant organisms. In regions like China, where CF is less common, the diagnosis may be delayed, complicating treatment outcomes. Understanding the interplay between CF and infections like Mycobacterium abscessus is crucial for improving patient management.
The patient was diagnosed with cystic fibrosis confirmed by elevated sweat chloride and CFTR mutations.
Mycobacterium abscessus was identified through metagenomic next-generation sequencing of bronchoalveolar lavage fluid.
Initial treatment included a combination of intravenous and oral antimycobacterial agents.
Clinical stability was achieved with a quadruple antimycobacterial regimen.
Challenges included limited access to CFTR modulator therapy due to financial constraints.
Clinical Implications
Healthcare providers should be vigilant for cystic fibrosis in patients presenting with respiratory symptoms, especially in regions where the disease is less common. Personalized antimicrobial strategies are essential for managing infections like Mycobacterium abscessus, particularly in the context of CF.
Conclusion
This case underscores the importance of early diagnosis and tailored treatment approaches in managing cystic fibrosis and its associated infections. Improved access to therapies is critical for optimizing patient outcomes.
